Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma

BACKGROUND: The introduction of immune checkpoint inhibitors has led to a survival benefit in patients with advanced melanoma; however data on the adoption of immunotherapy in the community are scarce. METHODS: Using the National Cancer Database, we identified 4725 patients aged ≥20 diagnosed with m...

Descripción completa

Detalles Bibliográficos
Autores principales: Krimphove, Marieke J., Tully, Karl H., Friedlander, David F., Marchese, Maya, Ravi, Praful, Lipsitz, Stuart R., Kilbridge, Kerry L., Kibel, Adam S., Kluth, Luis A., Ott, Patrick A., Choueiri, Toni K., Trinh, Quoc-Dien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836520/
https://www.ncbi.nlm.nih.gov/pubmed/31699149
http://dx.doi.org/10.1186/s40425-019-0782-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836520/
https://www.ncbi.nlm.nih.gov/pubmed/31699149
http://dx.doi.org/10.1186/s40425-019-0782-y

Ejemplares similares